Improving Women's Sexual Health While in Drug Addiction Treatment

Project: Research project


Introduction: Women treated for opioid dependence have a higher rate of unintended pregnancies (67%-86%) than the general population (49%). Given that opioid-dependent women have regular contact with health care providers during agonist-treatment, this setting is ideal for integrating unintended pregnancy interventions.
Objective: The proximal goal of this R34 proposal is to develop and initially evaluate a social-cognitive, theory-driven intervention, Sex and Female Empowerment (SAFE), designed to increase acceptance of and adherence to contraceptive practices among opioid-agonist-maintained women of childbearing age. SAFE comprises four 60-minute sessions that will be delivered in one of two formats: a face-to-face brief intervention approach or a novel, computer-adaptive platform. The distal goal is to determine the extent to which either or both SAFE delivery formats yield long-term contraceptive practice improvements for women in substance abuse treatment.
Effective start/end date9/30/138/31/16


  • NIH National Institute on Drug Abuse (NIDA)


Reproductive Health
Women's Health
Substance-Related Disorders
Opioid Analgesics
Contraceptive Agents
Pregnancy Rate
Health Personnel
Power (Psychology)